San Donato Hospital
Why choose Italy for immunotherapy?
Access advanced Immunotherapy solutions in trusted clinics from $6,500.
| Italy | Turkey | Austria | |
| Immunotherapy | ≈ $6,500 | from $3,000 | ≈ $9,000 |
| Sarcoma Immunotherapy | ≈ $50,000 | from $8,900 | ≈ $60,000 |
| Immunotherapy for prostate cancer | ≈ $50,000 | from $8,000 | ≈ $30,000 |
| Immunotherapy for lung cancer | ≈ $35,000 | from $8,000 | ≈ $30,000 |
| Immunotherapy for kidney cancer | ≈ $8,500 | from $8,000 | ≈ $28,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
Written by Kateryna Zamkovska
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
Immunotherapy treatments in Italy include immune checkpoint inhibitors like pembrolizumab and nivolumab, CAR-T cell therapy, and sublingual immunotherapy for allergies. These therapies are regulated by the Italian Medicines Agency and available at accredited centers like San Raffaele in Milan for oncology and hematology.
Bookimed Expert Insight: While many countries focus solely on cancer, Italy is a leader in diverse immunotherapy applications. San Raffaele in Milan, for instance, performed the first stem cell therapy for severe combined immune deficiency. This highlights Italy's expertise in cellular immunotherapy beyond standard oncology protocols.
Patient Consensus: Patients emphasize the importance of distinguishing between short-term allergy tablets and long-term cancer protocols. Monitoring for delayed side effects like fatigue or liver enzyme changes is a common practical concern during extended treatment cycles.
Immunotherapy is fully integrated into Italy's universal healthcare system and routinely reimbursed for regulatory-approved oncological indications. The Italian Medicines Agency centrally regulates and funds advanced treatments like immune checkpoint inhibitors and cellular therapies within standard public oncology care.
Bookimed Expert Insight: Patient volume data highlights a strategic pathway for navigating the public system. Major research hubs in Milan like San Raffaele treat 12,000 cancer patients annually. Choosing an institute with scientific accreditation speeds up access to modern biological therapies.
Patient Consensus: The public healthcare system covers expensive modern therapies at no cost after specialist referral. However, patients advise booking a private consultation with a public-system doctor to bypass regional waiting times.
Italy's Servizio Sanitario Nazionale (SSN) covers immunotherapy and other expensive cancer treatments for registered residents. These Essential Levels of Care (LEA) are generally free at public or accredited private hospitals. Patients typically only pay a small copayment, known as a ticket, for diagnostic tests or specialist consultations.
Bookimed Expert Insight: While the public system covers high-cost drugs like Keytruda, international patients often choose Milanese centers like San Raffaele for faster access to clinical trials. This clinic achieved the world's first stem cell therapy for severe immune deficiency. Public coverage is medically robust but navigating the paperwork takes time, making private oncology consultations a common way to speed up the initial diagnostic phase.
Patient Consensus: The public system provides excellent care for serious illnesses, though the administrative process can be slow. Residents suggest keeping tax codes and residency papers ready to avoid delays in starting life-saving treatments.
Accessing immunotherapy clinical trials in Italy requires a referral to a certified Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) center. Patients must consult an oncologist to verify eligibility against strict inclusion criteria like PD-L1 expression before searching official registries like the EU Clinical Trials Information System.
Bookimed Expert Insight: While many search globally, Italy stands out for specialized cellular therapies at IRCCS centers like San Raffaele. Data shows these facilities serve 300,000 patients annually and pioneered the world's first stem cell therapy for immune deficiency. Choosing a center with these specific credentials often indicates a stronger infrastructure for managing complex, late-stage immune reactions.
Patient Consensus: Patients emphasize that access depends on finding the exact National Clinical Trial ID rather than just the drug name. Success often involves checking if the research center accepts outside referrals early in the process.